This is a paid advertisement for legal services. Sponsor and responsible law firm: JAG Legal Group, using the 1-800-LAW-FIRM brand.

Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor’s advice can result in injury or death. Consult your physician before making any decision regarding prescribed medication or medical treatment.

Gabapentin and pregabalin remain FDA-approved for their approved indications. This advertisement is not an FDA notice or a product recall. Research findings do not establish that a medicine caused an individual injury. Jurisdiction and representation disclosures.

LEGAL INFORMATION FOR PATIENTS & FAMILIES Attorney advertising · JAG Legal Group
RESEARCH & SAFETY

Gabapentin litigation headlines: what a court record can tell you

Understand the November federal MDL report, the limits of lawsuit headlines and why deadlines require individual review.

JAG Legal Group · Published November 9, 2026

Published November 9, 2026 · Federal report dated November 2, 2026

What the federal report shows

The Judicial Panel on Multidistrict Litigation publishes reports of active federal proceedings. Its November 2, 2026 report by MDL number does not list a gabapentin- or Neurontin-dementia MDL. This is a dated check of that report, not a claim that no individual lawsuits or state coordination exist.

Coordination is not a decision on liability

An MDL brings related federal cases together for pretrial proceedings. State-court coordination is a different process. Neither the filing of a complaint nor the grouping of cases proves that a medicine caused an injury. A complaint contains allegations; a court order must be read for what it actually decides.

Before relying on a report about a coordinated program, ask for the court, docket number and underlying order. This guide does not announce a verified new state coordination order, case count, settlement or claims deadline.

A headline does not determine your eligibility

Research categories such as prescription counts and age groups are not universal legal eligibility rules. A study population does not determine whether a particular patient has a claim. Gabapentin and pregabalin are different drugs, and the product supplied at each fill needs to be identified. Our research guide separates associations from proof of causation.

Preserve dates and get individual advice

Keep your first and last use dates, symptom onset, diagnosis date, pharmacy records and the places where treatment occurred. Deadlines may depend on jurisdiction and facts; this guide supplies no single nationwide cutoff. Contacting a firm does not file suit or pause time limits. See understanding a potential claim and the records checklist. JAG Legal Group must assess any proposed matter individually. No result is guaranteed.

A state-court complaint is a different record

Updated November 16, 2026: the Seifers complaint guide examines a court-stamped Philadelphia filing dated September 25. Its existence is consistent with the limited scope of the federal report. It supplies no verified state coordination order or universal claims deadline.

YOUR NEXT STEP

You don’t have to sort
through this alone.

Talk through your concerns and learn what information a legal review may require.

Call 1-800-LAW-FIRM ↗

1-800-529-3476 · No obligation to retain a lawyer

Request a reviewCall 1-800-LAW-FIRM ↗